Wikidata

(Q65473726)

English

Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

short name
LUCID (English)
0 references
title
A Randomized, Open Label, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Lumiliximab in Combination With Fludarabine, Cyclophosphamide, and Rituximab Versus Fludarabine, Cyclophosphamide, and Rituximab Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
Czech Republic
0 references
France
0 references
Germany
0 references
Greece
0 references
India
0 references
Israel
0 references
Italy
0 references
Lithuania
0 references
New Zealand
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Slovakia
0 references
Spain
0 references
United Kingdom
0 references
start time
November 2006
0 references
end time
July 2010
0 references
number of participants
627
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65473726&oldid=2192283251"